Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 104Stomach Neoplasms 19Inflammatory Breast Neoplasms 12Esophageal Neoplasms 11Triple Negative Breast Neoplasms 6Sarcoma 6Carcinoma, Hepatocellular 5Lymphoma, Large B-Cell, Diffuse 4Liver Neoplasms 4Adenocarcinoma Of Esophagus 4Primary Breast Cancer 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Hemangiosarcoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Lymphoma, B-Cell, Marginal Zone 2Liposarcoma 2Hemangiopericytoma, Malignant 2Gallbladder Neoplasms 2Fibrosarcoma 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Carcinoma, Ductal, Breast 2Breast Neoplasms, Male 2

Interventions

Zoledronic Acid 1Trastuzumab 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Micrometastasis × Epirubicin × Clear all
NCT00242203 2013-08-13

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Washington University School of Medicine

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡